As of June 20, 2025, Genetron Holdings Ltd (GTH) reports a Current Ratio of 1.82.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Genetron Holdings Ltd's Current Ratio
Over recent years, Genetron Holdings Ltd's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2022-12-31 | 1.82 |
| 2021-12-31 | 4.70 |
| 2020-12-31 | 7.81 |
| 2019-12-31 | 2.02 |
| 2018-12-31 | 3.40 |
This gradual decrease highlights how Genetron Holdings Ltd manages its short-term assets and liabilities over time.
Comparing Genetron Holdings Ltd's Current Ratio to Peers
To better understand Genetron Holdings Ltd's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Genetron Holdings Ltd (GTH) | 1.82 |
| LogicBio Therapeutics Inc (LOGC) | 31.20 |
| Sernova Corp (SVA.V) | 19.19 |
| Imeik Technology Development Co Ltd (300896.SZ) | 14.67 |
| MediciNova Inc (MNOV) | 13.88 |
| Corbus Pharmaceuticals Holdings Inc (CRBP) | 12.75 |
Compared to its competitors, Genetron Holdings Ltd's Current Ratio is among the lowest compared to peers, suggesting tighter liquidity management or potential short-term obligations concerns.